Michael L. Graham - Concepedia

Concepedia

Author

Michael L. Graham

Duke Medical Center

Also Known As

M L Graham, M. L. Graham, M.L. Graham, MICHAEL L. GRAHAM, Michael L Graham, Michael L. Graham

34

Publications

1.8K

Citations

16

H-Index

55

Concepts

All Affiliations

Duke Medical Center Johns Hopkins University University of Arizona Duke University University of Florida

ML

About

Michael L. Graham is an author at Duke Medical Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	459
2	Blood Transplantation	2	2	121
3	Health Sciences	1	1	81
4	Art History	1	1	81
5	Biomedical Engineering	1	1	40

Michael L. Graham

×

20

Publications

1.8K

Citations

16

H-Index

	Year	Citations
Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients Joanne Kurtzberg, Mary Laughlin, Michael L. Graham, New England Journal of Medicine	1996	1K
High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. Michael L. Graham, James E. Herndon, Joseph R. Casey, Journal of Clinical Oncology	1997	170
Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation Into Unrelated Recipients Joanne Kurtzberg, Mary Laughlin, Michael L. Graham, Obstetrical & Gynecological Survey ImmunologyStem Cell MobilizationStem Cell TransplantationHematologyTransplantation Into	1997	81
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults Timothy A. Driscoll, Lolie C. Yu, Haydar Frangoul, Antimicrobial Agents and Chemotherapy PharmacotherapyImmunocompromised ChildrenPharmacodynamic ModelingPre-clinical PharmacologyDrug Resistance	2011	62
Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose Cyclophosphamide Geoffrey McCowage, R D Tien, Roger E. McLendon, Medical and Pediatric Oncology Neuro-oncologyPediatric Brain TumorsSuccessful TreatmentHigh-dose CyclophosphamidePediatric Neurosurgery	1996	52
Economic Comparison of Home-Care-Based versus Hospital-Based Treatment of Chemotherapy-Induced Febrile Neutropenia in Children Dennis W. Raisch, Mark T. Holdsworth, Stuart S. Winter, Value in Health Pediatric Emergency MedicineHealth EconomicsPediatric HematologyPediatricsOutcomes Research	2003	41
Analysis of Hematopoietic Cell Transplants Using Plasma-Depleted Cord Blood Products That Are Not Red Blood Cell Reduced Robert Chow, Auayporn Nademanee, Joseph Rosenthal, Biology of Blood and Marrow Transplantation TransplantationHematologyCord BloodBiomedical EngineeringBlood Transplantation	2007	40
Reversible leukoencephalopathy associated with graft-versus-host disease: MR findings. James M. Provenzale, Michael L. Graham PubMed	1996	36
Pharmacology and toxicity of a potent "nonclassical" 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs. Eleanor C. Weir, Arlene R. Cashmore, Robert N. Dreyer, PubMed Molecular PharmacologyPharmacological StudyAntiparasitic AgentMedicineNormal Dogs	1982	33
Phase I Trial of Trimetrexate Glucuronate on a Five-Day Bolus Schedule: Clinical Pharmacology and Pharmacodynamics L B Grochow, D A Noe, GB Dole, JNCI Journal of the National Cancer Institute Five-day Bolus SchedulePharmacotherapyMetronomic ChemotherapyPharmacodynamic ModelingPre-clinical Pharmacology	1989	32

Page 1